Paper6207933
5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination.
Konieczny SF and 1 other. Cell, 1984. Cited by 282 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. 5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination. Papers, record 6207933. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6207933
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Azacitidine | Major topic |
| Genes, Regulator | Major topic |
| Mesoderm | Major topic |
| Adipose Tissue | |
| Animals | |
| Cartilage | |
| Cell Differentiation | |
| Cell Line | |
| Cytoskeletal Proteins | |
| Embryo, Mammalian | |
| Mice | |
| Mice, Inbred C3H | |
| Muscles |
Source PubMed
Cited by90
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 282 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,044,248 | Dissecting the impact of transcription factor dose on cell reprogramming heterogeneity using scTF-seq. | Nat Genet | 2025 | https://conductscience.org/library/papers/41044248 | PubMed |
| 40,683,107 | Cell and tissue reprogramming: Unlocking a new era in medical drug discovery. | Pharmacol Rev | 2025 | https://conductscience.org/library/papers/40683107 | PubMed |
| 39,474,325 | Environmental Obesogens and Their Perturbations in Lipid Metabolism. | Environ Health (Wash) | 2024 | https://conductscience.org/library/papers/39474325 | PubMed |
| 39,380,256 | TGF-β effects on adipogenesis of 3T3-L1 cells differ in 2D and 3D cell culture conditions. | FEBS Open Bio | 2024 | https://conductscience.org/library/papers/39380256 | PubMed |
| 39,143,643 | Lesson on obesity and anatomy of adipose tissue: new models of study in the era of clinical and translational research. | J Transl Med | 2024 | https://conductscience.org/library/papers/39143643 | PubMed |
| 38,344,322 | Adipose-Derived Mesenchymal Stem Cells Differentiation Toward Cardiomyocyte-Like Cells on the PCL/PANI Nanofibrous Scaffold: An Experimental Study. | Iran J Biotechnol | 2022 | https://conductscience.org/library/papers/38344322 | PubMed |
| 37,571,382 | Adipose Tissue Hyperplasia and Hypertrophy in Common and Syndromic Obesity-The Case of BBS Obesity. | Nutrients | 2023 | https://conductscience.org/library/papers/37571382 | PubMed |
| 36,359,831 | MyoD-Induced Trans-Differentiation: A Paradigm for Dissecting the Molecular Mechanisms of Cell Commitment, Differentiation and Reprogramming. | Cells | 2022 | https://conductscience.org/library/papers/36359831 | PubMed |
| 35,889,891 | Vitamin K2 Improves Osteogenic Differentiation by Inhibiting STAT1 via the Bcl-6 and IL-6/JAK in C3H10 T1/2 Clone 8 Cells. | Nutrients | 2022 | https://conductscience.org/library/papers/35889891 | PubMed |
| 35,540,854 | Yixin-Shu facilitated cardiac-like differentiation of mesenchymal stem cells in vitro. | RSC Adv | 2018 | https://conductscience.org/library/papers/35540854 | PubMed |
| 34,473,703 | DHA but not EPA induces the trans-differentiation of C2C12 cells into white-like adipocytes phenotype. | PLoS One | 2021 | https://conductscience.org/library/papers/34473703 | PubMed |
| 34,459,412 | The Satellite Cell at 60: The Foundation Years. | J Neuromuscul Dis | 2021 | https://conductscience.org/library/papers/34459412 | PubMed |
| 33,092,038 | Modeling Adipogenesis: Current and Future Perspective. | Cells | 2020 | https://conductscience.org/library/papers/33092038 | PubMed |
| 32,595,696 | Concurrent EPA and DHA Supplementation Impairs Brown Adipogenesis of C2C12 Cells. | Front Genet | 2020 | https://conductscience.org/library/papers/32595696 | PubMed |
| 31,996,252 | TGF-β/SMAD signaling regulation of mesenchymal stem cells in adipocyte commitment. | Stem Cell Res Ther | 2020 | https://conductscience.org/library/papers/31996252 | PubMed |
| 31,936,485 | 25-Hydroxycholesterol Inhibits Adipogenic Differentiation of C3H10T1/2 Pluripotent Stromal Cells. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/31936485 | PubMed |
| 31,700,701 | Effects of eicosapentaenoic acid and docosahexaenoic acid on C2C12 cell adipogenesis and inhibition of myotube formation. | Anim Cells Syst (Seoul) | 2019 | https://conductscience.org/library/papers/31700701 | PubMed |
| 29,887,393 | Shaping Gene Expression by Landscaping Chromatin Architecture: Lessons from a Master. | Mol Cell | 2018 | https://conductscience.org/library/papers/29887393 | PubMed |
| 29,097,153 | Finding MyoD and lessons learned along the way. | Semin Cell Dev Biol | 2017 | https://conductscience.org/library/papers/29097153 | PubMed |
| 29,021,781 | Cross Talk between Adipose Tissue and Placenta in Obese and Gestational Diabetes Mellitus Pregnancies via Exosomes. | Front Endocrinol (Lausanne) | 2017 | https://conductscience.org/library/papers/29021781 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6207933
GET https://conductscience.org/api/papers/v1/6207933/cited_by?page=2